Chemerin as a biomarker at the intersection of inflammation, coagulation, fibrinolysis and metabolism in resectable Non-Small Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) constitutes the overwhelming majority (85%) of lung carcinoma cases being the leading cause of cancer-related death globally [1]. Intrigued and multifactorial in its nature, the etiopathogenesis of NSCLC incorporates an aggregate of inherent determinants and environmental factors including mainly smoking, family history, lifestyle, professional, infectious and dietary risk factors [2,3]. Due to its dismal prognosis, there is a tremendous interest in identifying emerging biomarkers implicated in NSCLC pathogenesis to optimize its early diagnosis and management.

Source: Lung Cancer - October 9, 2018 Category: Cancer & Oncology Authors: George P. Sotiropoulos, Maria Dalamaga, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Marianna Kotopouli, Irene Karampela, Gerasimos Socrates Christodoulatos, Antigoni Lekka, Athanasios G. Papavassiliou Source Type: research